tiprankstipranks
Advertisement
Advertisement

HK:0719 Stock Latest News

Xinhua Pharmaceutical Wins NMPA Approval for New Electrolyte Injection
Company AnnouncementsXinhua Pharmaceutical Wins NMPA Approval for New Electrolyte Injection
6d ago
Xinhua Pharmaceutical Wins Approval to Take Over Galculus Bovis and Metronidazole Capsule Rights
PremiumCompany Announcements
Xinhua Pharmaceutical Wins Approval to Take Over Galculus Bovis and Metronidazole Capsule Rights
12d ago
Shandong Xinhua Pharmaceutical Announces Retirement of Non-Executive Director
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Announces Retirement of Non-Executive Director
13d ago
Shandong Xinhua Pharmaceutical Sets Out Board and Committee Structure
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Sets Out Board and Committee Structure
13d ago
Shandong Xinhua Pharma Moves to Update Articles After Share Capital Increase
PremiumCompany Announcements
Shandong Xinhua Pharma Moves to Update Articles After Share Capital Increase
17d ago
Shandong Xinhua Pharmaceutical Proposes RMB 0.15 Final Dividend for 2025
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Proposes RMB 0.15 Final Dividend for 2025
17d ago
Shandong Xinhua Pharmaceutical Publishes Audited 2025 Annual Results
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Publishes Audited 2025 Annual Results
17d ago
Shandong Xinhua Unit Wins NMPA Approval for Ibuprofen Granules
Premium
Company Announcements
Shandong Xinhua Unit Wins NMPA Approval for Ibuprofen Granules
21d ago
Shandong Xinhua Pharmaceutical Wins Approval to Take Over Ezetimibe Marketing Rights
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins Approval to Take Over Ezetimibe Marketing Rights
28d ago
Shandong Xinhua Pharma Sets March 27 Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Shandong Xinhua Pharma Sets March 27 Board Meeting to Approve 2025 Results
1M ago
Shandong Xinhua Unit Wins China Approval for Saxagliptin-Metformin Tablets
PremiumCompany Announcements
Shandong Xinhua Unit Wins China Approval for Saxagliptin-Metformin Tablets
1M ago
Shandong Xinhua Pharmaceutical Wins Approval for Entacapone Tablets in China
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins Approval for Entacapone Tablets in China
1M ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Glucosamine Sulfate Capsules
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Wins NMPA Approval for Glucosamine Sulfate Capsules
2M ago
Shandong Xinhua Pharmaceutical Drops Planned Equity Acquisition with Novo Sana
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Drops Planned Equity Acquisition with Novo Sana
2M ago
Shandong Xinhua Pharmaceutical Tightens Audit Committee Governance Framework
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Tightens Audit Committee Governance Framework
3M ago
Shandong Xinhua Pharmaceutical Tightens Governance With Revised Nomination Committee Charter
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Tightens Governance With Revised Nomination Committee Charter
3M ago
Shandong Xinhua Pharmaceutical Updates Remuneration and Appraisal Committee Mandate
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Updates Remuneration and Appraisal Committee Mandate
3M ago
Shandong Xinhua Pharmaceutical Wins China Approval for Valsartan Hypertension Capsules
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins China Approval for Valsartan Hypertension Capsules
4M ago
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Phloroglucinol Injection
PremiumCompany Announcements
Shandong Xinhua Pharmaceutical Wins NMPA Approval for Phloroglucinol Injection
4M ago
Shandong Xinhua Pharmaceutical Wins Approval for Oseltamivir Suspension in China
PremiumCompany AnnouncementsShandong Xinhua Pharmaceutical Wins Approval for Oseltamivir Suspension in China
4M ago
Shandong Xinhua’s Epinephrine Injection Gains Regulatory Approval
Premium
Company Announcements
Shandong Xinhua’s Epinephrine Injection Gains Regulatory Approval
5M ago
Shandong Xinhua Pharmaceutical Gains Approval for Prednisolone Acetate
Premium
Company Announcements
Shandong Xinhua Pharmaceutical Gains Approval for Prednisolone Acetate
5M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >